- Home
- BRBS vs ESPR Comparison
BRBS vs ESPR Comparison
Compare BRBS & ESPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRBS
- ESPR
- Stock Information
- Founded
- BRBS 1893
- ESPR 2008
- Country
- BRBS United States
- ESPR United States
- Employees
- BRBS N/A
- ESPR N/A
- Industry
- BRBS Commercial Banks
- ESPR Biotechnology: Pharmaceutical Preparations
- Sector
- BRBS Finance
- ESPR Health Care
- Exchange
- BRBS Nasdaq
- ESPR Nasdaq
- Market Cap
- BRBS 290.6M
- ESPR 305.0M
- IPO Year
- BRBS N/A
- ESPR 2013
- Fundamental
- Price
- BRBS $3.31
- ESPR $1.39
- Analyst Decision
- BRBS
- ESPR Buy
- Analyst Count
- BRBS 0
- ESPR 7
- Target Price
- BRBS N/A
- ESPR $6.36
- AVG Volume (30 Days)
- BRBS 210.7K
- ESPR 4.5M
- Earning Date
- BRBS 04-29-2025
- ESPR 03-04-2025
- Dividend Yield
- BRBS N/A
- ESPR N/A
- EPS Growth
- BRBS N/A
- ESPR N/A
- EPS
- BRBS N/A
- ESPR N/A
- Revenue
- BRBS $97,334,000.00
- ESPR $332,314,000.00
- Revenue This Year
- BRBS N/A
- ESPR $5.51
- Revenue Next Year
- BRBS N/A
- ESPR $1.42
- P/E Ratio
- BRBS N/A
- ESPR N/A
- Revenue Growth
- BRBS N/A
- ESPR 185.66
- 52 Week Low
- BRBS $2.45
- ESPR $1.35
- 52 Week High
- BRBS $3.83
- ESPR $3.94
- Technical
- Relative Strength Index (RSI)
- BRBS 46.24
- ESPR 33.54
- Support Level
- BRBS $3.20
- ESPR $1.35
- Resistance Level
- BRBS $3.31
- ESPR $1.75
- Average True Range (ATR)
- BRBS 0.07
- ESPR 0.09
- MACD
- BRBS 0.00
- ESPR -0.01
- Stochastic Oscillator
- BRBS 51.16
- ESPR 10.00
About BRBS Blue Ridge Bankshares Inc.
Blue Ridge Bankshares Inc is a United States-based company engaged in offering commercial and consumer banking and financial services through its wholly-owned bank subsidiary, Blue Ridge Bank, National Association, and its non-bank financial services affiliates. The bank offers services such as checking accounts, savings accounts, money market accounts, cash management accounts, commercial and industrial loans, residential mortgages, commercial mortgages, home equity loans, consumer installment loans, investment accounts, insurance and others. It has three reportable business segments: commercial banking, mortgage banking, and holding company activities.
About ESPR Esperion Therapeutics Inc.
Esperion Therapeutics Inc is a pharmaceutical company. It specializes in developing and commercializing accessible, oral, once-daily, non-statin medicines for patients struggling with elevated low-density lipoprotein cholesterol. The firm has the business of researching, developing and commercializing therapies for the treatment of patients with the elevated low-density lipoprotein cholesterol operating segment. Its products include NEXLETOL, NEXLIZET, NILEMDO and NUSTENDI. The Company manages its business in one operating segment, which is the business of researching, developing and commercializing therapies for the treatment of patients with elevated LDL-C.